PMC:7405836 / 106597-106814 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T955","span":{"begin":99,"end":107},"obj":"Disease"},{"id":"T956","span":{"begin":99,"end":103},"obj":"Disease"},{"id":"T957","span":{"begin":201,"end":216},"obj":"Disease"},{"id":"T958","span":{"begin":207,"end":216},"obj":"Disease"}],"attributes":[{"id":"A955","pred":"mondo_id","subj":"T955","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A956","pred":"mondo_id","subj":"T956","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A957","pred":"mondo_id","subj":"T957","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A958","pred":"mondo_id","subj":"T958","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Ribavirin, penciclovir, and favipiravir might not possess noteworthy in vivo antiviral actions for SARS-CoV-2, since higher concentrations of these nucleoside analogs are needed in vitro to lessen the viral infection."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T95853","span":{"begin":11,"end":22},"obj":"Chemical"},{"id":"T87107","span":{"begin":28,"end":39},"obj":"Chemical"},{"id":"T45708","span":{"begin":77,"end":86},"obj":"Chemical"},{"id":"T14781","span":{"begin":148,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A98581","pred":"chebi_id","subj":"T95853","obj":"http://purl.obolibrary.org/obo/CHEBI_7956"},{"id":"A5660","pred":"chebi_id","subj":"T87107","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A92234","pred":"chebi_id","subj":"T45708","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A42420","pred":"chebi_id","subj":"T14781","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"}],"text":"Ribavirin, penciclovir, and favipiravir might not possess noteworthy in vivo antiviral actions for SARS-CoV-2, since higher concentrations of these nucleoside analogs are needed in vitro to lessen the viral infection."}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T8","span":{"begin":201,"end":216},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"Ribavirin, penciclovir, and favipiravir might not possess noteworthy in vivo antiviral actions for SARS-CoV-2, since higher concentrations of these nucleoside analogs are needed in vitro to lessen the viral infection."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T729","span":{"begin":0,"end":217},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ribavirin, penciclovir, and favipiravir might not possess noteworthy in vivo antiviral actions for SARS-CoV-2, since higher concentrations of these nucleoside analogs are needed in vitro to lessen the viral infection."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2859","span":{"begin":99,"end":109},"obj":"Species"},{"id":"2877","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"2878","span":{"begin":11,"end":22},"obj":"Chemical"},{"id":"2879","span":{"begin":28,"end":39},"obj":"Chemical"},{"id":"2880","span":{"begin":148,"end":158},"obj":"Chemical"},{"id":"2886","span":{"begin":201,"end":216},"obj":"Disease"}],"attributes":[{"id":"A2859","pred":"tao:has_database_id","subj":"2859","obj":"Tax:2697049"},{"id":"A2877","pred":"tao:has_database_id","subj":"2877","obj":"MESH:D012254"},{"id":"A2878","pred":"tao:has_database_id","subj":"2878","obj":"MESH:C053539"},{"id":"A2879","pred":"tao:has_database_id","subj":"2879","obj":"MESH:C462182"},{"id":"A2880","pred":"tao:has_database_id","subj":"2880","obj":"MESH:D009705"},{"id":"A2886","pred":"tao:has_database_id","subj":"2886","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ribavirin, penciclovir, and favipiravir might not possess noteworthy in vivo antiviral actions for SARS-CoV-2, since higher concentrations of these nucleoside analogs are needed in vitro to lessen the viral infection."}